☰

Duane A. Burnett - Publications

Affiliations: 
1981-1986 Chemistry Ohio State University, Columbus, Columbus, OH 
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Peng X, Holler CJ, Alves AF, Oliviera MG, Speake M, Pugliese A, Oskouei MR, de Freitas ID, Chen AY, Gallegos R, McTighe SM, Koenig G, Hurst RS, Blain JF, Lanter JC, ... Burnett DA, et al. Discovery and characterization of novel TRPML1 agonists. Bioorganic & Medicinal Chemistry Letters. 98: 129595. PMID 38141860 DOI: 10.1016/j.bmcl.2023.129595  0.303
2016 Wu WL, Burnett DA, Clader J, Greenlee WJ, Jiang Q, Hyde LA, Del Vecchio RA, Cohen-Williams ME, Song L, Lee J, Terracina G, Zhang Q, Nomeir A, Parker EM, Zhang L. Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 27836402 DOI: 10.1016/j.bmcl.2016.04.095  0.493
2016 Pissarnitski DA, Zhao Z, Cole D, Wu WL, Domalski M, Clader JW, Scapin G, Voigt J, Soriano A, Kelly T, Powles MA, Yao Z, Burnett DA. Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors. Bioorganic & Medicinal Chemistry. PMID 27670099 DOI: 10.1016/j.bmc.2016.09.007  0.484
2016 Wu WL, Hao J, Domalski M, Burnett DA, Pissarnitski D, Zhao Z, Stamford A, Scapin G, Gao YD, Soriano A, Kelly TM, Yao Z, Powles MA, Chen S, Mei H, et al. Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. Acs Medicinal Chemistry Letters. 7: 498-501. PMID 27190600 DOI: 10.1021/acsmedchemlett.6b00027  0.527
2015 Zhao Z, Pissarnitski DA, Josien H, Wu WL, Xu R, Li H, Clader J, Burnett DA, Terracina G, Hyde L, Lee J, Song L, Zhang L. Discovery of a novel, potent spirocyclic series of γ-secretase inhibitors. Journal of Medicinal Chemistry. PMID 26496070 DOI: 10.1021/acs.jmedchem.5b00774  0.534
2013 Wu WL, Sasikumar TK, Domalski MS, Qiang L, Burnett DA, Clader J, Greenlee WJ, Chan TM, Lee J, Zhang L. A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 850-3. PMID 23265902 DOI: 10.1016/j.bmcl.2012.11.054  0.484
2013 Wu WL, Asberom T, Bara T, Bennett C, Burnett DA, Clader J, Domalski M, Greenlee WJ, Josien H, McBriar M, Rajagopalan M, Vicarel M, Xu R, Hyde LA, Del Vecchio RA, et al. Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 844-9. PMID 23265892 DOI: 10.1016/j.bmcl.2012.11.047  0.505
2012 Huang X, Zhou W, Liu X, Li H, Sun G, Mandal M, Vicarel M, Zhu X, Bennett C, McCraken T, Pissarnitski D, Zhao Z, Cole D, Gallo G, Zhu Z, ... ... Burnett D, et al. Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease. Acs Medicinal Chemistry Letters. 3: 931-5. PMID 24900409 DOI: 10.1021/ml300209g  0.307
2012 Wu WL, Domalski M, Burnett DA, Josien H, Bara T, Rajagopalan M, Xu R, Clader J, Greenlee WJ, Brunskill A, Hyde LA, Del Vecchio RA, Cohen-Williams ME, Song L, Lee J, et al. Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease. Acs Medicinal Chemistry Letters. 3: 892-6. PMID 24900404 DOI: 10.1021/ml300044f  0.519
2012 Brumfield S, Korakas P, Silverman LS, Tulshian D, Matasi JJ, Qiang L, Bennett CE, Burnett DA, Greenlee WJ, Knutson CE, Wu WL, Sasikumar TK, Domalski M, Bertorelli R, Grilli M, et al. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22: 7223-6. PMID 23084894 DOI: 10.1016/J.Bmcl.2012.09.048  0.7
2012 Bennett CE, Burnett DA, Greenlee WJ, Knutson CE, Korakas P, Li C, Tulshian D, Wu WL, Bertorelli R, Fredduzzi S, Grilli M, Lozza G, Reggiani A, Veltri A. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22: 1575-8. PMID 22266036 DOI: 10.1016/J.Bmcl.2011.12.131  0.699
2011 Xu R, Cole D, Asberom T, Bara T, Bennett C, Burnett DA, Clader J, Domalski M, Greenlee WJ, Hyde L, Josien H, Li H, McBriar M, McKittrick B, Pissarnitski D, et al. SAR of tricyclic sulfones as γ-secretase inhibitors Science China Chemistry. 54: 1688-1701. DOI: 10.1007/s11426-011-4388-6  0.473
2010 Smith EM, Sorota S, Kim HM, McKittrick BA, Nechuta TL, Bennett C, Knutson C, Burnett DA, Kieselgof J, Tan Z, Rindgen D, Bridal T, Zhou X, Jia YP, Dong Z, et al. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis. Bioorganic & Medicinal Chemistry Letters. 20: 4602-6. PMID 20580233 DOI: 10.1016/j.bmcl.2010.06.012  0.685
2010 Sasikumar TK, Qiang L, Burnett DA, Cole D, Xu R, Li H, Greenlee WJ, Clader J, Zhang L, Hyde L. Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 20: 3632-5. PMID 20493690 DOI: 10.1016/j.bmcl.2010.04.104  0.31
2010 Sasikumar TK, Burnett DA, Asberom T, Wu WL, Bennett C, Cole D, Xu R, Greenlee WJ, Clader J, Zhang L, Hyde L. Tetracyclic sulfones as potent gamma-secretase inhibitors: synthesis and structure-activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 20: 3645-8. PMID 20471254 DOI: 10.1016/j.bmcl.2010.04.103  0.516
2010 Xu R, Cole D, Asberom T, Bara T, Bennett C, Burnett DA, Clader J, Domalski M, Greenlee W, Hyde L, Josien H, Li H, McBriar M, McKittrick B, McPhail AT, et al. Design and synthesis of tricyclic sulfones as gamma-secretase inhibitors with greatly reduced Notch toxicity. Bioorganic & Medicinal Chemistry Letters. 20: 2591-6. PMID 20236824 DOI: 10.1016/j.bmcl.2010.02.080  0.524
2009 Sasikumar TK, Qiang L, Burnett DA, Greenlee WJ, Li C, Heimark L, Pramanik B, Grilli M, Bertorelli R, Lozza G, Reggiani A. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 19: 3199-203. PMID 19433355 DOI: 10.1016/J.Bmcl.2009.04.104  0.345
2007 Wu WL, Burnett DA, Domalski M, Greenlee WJ, Li C, Bertorelli R, Fredduzzi S, Lozza G, Veltri A, Reggiani A. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain. Journal of Medicinal Chemistry. 50: 5550-3. PMID 17929793 DOI: 10.1021/jm070590c  0.512
2006 Sasikumar TK, Qiang L, Wu WL, Burnett DA, Greenlee WJ, O'Neill K, Hawes BE, van Heek M, Graziano M. Tetrahydroisoquinolines as MCH-R1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16: 4917-21. PMID 16824753 DOI: 10.1016/j.bmcl.2006.06.055  0.496
2006 Wu WL, Burnett DA, Caplen MA, Domalski MS, Bennett C, Greenlee WJ, Hawes BE, O'Neill K, Weig B, Weston D, Spar B, Kowalski T. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16: 3674-8. PMID 16690315 DOI: 10.1016/j.bmcl.2006.04.062  0.52
2006 Wu WL, Burnett DA, Spring R, Qiang L, Sasikumar TK, Domalski MS, Greenlee WJ, O'Neill K, Hawes BE. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16: 3668-73. PMID 16690312 DOI: 10.1016/j.bmcl.2006.04.061  0.523
2005 Wu WL, Burnett DA, Spring R, Greenlee WJ, Smith M, Favreau L, Fawzi A, Zhang H, Lachowicz JE. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists. Journal of Medicinal Chemistry. 48: 680-93. PMID 15689153 DOI: 10.1021/jm030614p  0.477
2002 Wu WL, Caplen MA, Domalski MS, Zhang H, Fawzi A, Burnett DA. Synthesis and structure-activity relationships of aminoalkylazetidines as ORL1 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 12: 3157-60. PMID 12372523 DOI: 10.1016/S0960-894X(02)00652-2  0.467
1987 Keck GE, Burnett DA. β-Stannyl enones as radical traps: A very direct route to PGF2α Journal of Organic Chemistry. 52: 2958-2960. DOI: 10.1021/Jo00389A069  0.514
1987 Burnett DA, Hart DJ. Conformational effects on the oxidative coupling of benzyltetrahydroisoquinolines to morphinane and aporphine alkaloids Journal of Organic Chemistry. 52: 5662-5667. DOI: 10.1021/Jo00235A004  0.455
1986 Burnett DA, Hart DJ, Liu J. .beta.-Lactams from esters and sulfenimines: a new route to monobactams The Journal of Organic Chemistry. 51: 1929-1930. DOI: 10.1021/Jo00360A061  0.463
1986 Burnett DA, Hart DJ, Liu J. β-Lactams from esters and sulfenimines: A new route to monobactams Journal of Organic Chemistry. 51: 1929-1930. DOI: 10.1002/Chin.198645178  0.42
1985 Burnett DA, Gallucci JC, Hart DJ. Synthesis of 3-(1-hydroxyethyl)-2-azetidinones via ester-imine condensations Journal of Organic Chemistry. 50: 5120-5123. DOI: 10.1002/Chin.198621167  0.503
1984 Burnett DA, Choi JK, Hart DJ, Tsai YM. Pyrrolizidinone and indolizidinone synthesis: Generation and intramolecular addition of α-acylamino radicals to olefins and allenes Journal of the American Chemical Society. 106: 8201-8209.  0.412
Show low-probability matches.